N
NanoViricides
Shelton, United States
Founded 2005 NYSE: NNVC
About
Developer of nanoviricide drugs designed to attack and destroy viruses
Company Details
- Type
- commercial
- Employees
- 10-50
- Funding
- $100M+
Key Products
- NV-CoV-2
- Anti-viral Nanomedicines